| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/08/1993 | CN1079159A Technique for producing medicinal herbs in small pieces or slices ready for decoction |
| 12/08/1993 | CN1079147A Urapidil slow-release preparation |
| 12/08/1993 | CN1079146A Drug material suitable for micronisation |
| 12/08/1993 | CN1079109A Health care type chewing gum |
| 12/07/1993 | US5268368 Cyclophosphamide--amino acid lyophilizates |
| 12/07/1993 | US5268364 Block addition of a serine or threonine residue to protein |
| 12/07/1993 | US5268209 Nicotine packaging materials |
| 12/07/1993 | US5268182 Coating contains ethyl cellulose or methyl methacrylate; plasticizer and detackifying agent |
| 12/07/1993 | US5268181 Method of using niacin to control nocturnal cholesterol synthesis |
| 12/07/1993 | US5268180 Encapsulating aqueous phase |
| 12/07/1993 | US5268179 Ultrasonically sealed transdermal drug delivery systems |
| 12/07/1993 | US5268178 Two phase antibiotic elution rate; carrier is polymer of lactic and(or) glycolic acid |
| 12/07/1993 | US5268110 Oil removing method |
| 12/07/1993 | CA1324961C Oral anesthetic composition containing dyclonine |
| 12/07/1993 | CA1324960C Procedure for obtaining the preparation for the treatment of the disease psoriasis drug for the treatment of psoriasis and its application |
| 12/07/1993 | CA1324958C Compositions for coating food additives intended for ruminants and food additives so coated |
| 12/07/1993 | CA1324957C Composition containing an active ingredient for feeding ruminants, and its preparation |
| 12/07/1993 | CA1324864C Prosthetic disc containing therapeutic material |
| 12/06/1993 | EP0608217A4 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition. |
| 12/02/1993 | DE4217842A1 Pharmaceutical compsns. for intravenous or intra-coronary admin. - are aq. emulsions contg. 1,4-di:hydro:pyridine calcium antagonist, natural oil and phosphatidyl-choline or phosphatidyl-ethanolamine |
| 12/02/1993 | CA2358076A1 Topical patch for liposomal drug delivery system |
| 12/01/1993 | EP0572271A2 Acyl lactylates as antimicrobial actives |
| 12/01/1993 | EP0572190A1 Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient |
| 12/01/1993 | EP0572159A1 Medicament for the treatment of vulvar dystrophy or vaginal dryness |
| 12/01/1993 | EP0572049A2 Liposomes |
| 12/01/1993 | EP0571973A2 Slow-release sodium valproate tablets |
| 12/01/1993 | EP0571724A1 Stabilizer for phospholipid vesicles |
| 12/01/1993 | EP0571671A1 A Pharmaceutical composition in powder form |
| 12/01/1993 | EP0571669A1 Benzenedimethanol derivatives suitable for micronisation |
| 12/01/1993 | EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 12/01/1993 | EP0571597A1 Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals |
| 12/01/1993 | EP0571575A1 Unbuffered premixed ranitidine formulation |
| 12/01/1993 | EP0571513A1 Method of microencapsulation of hyperbaric gas. |
| 12/01/1993 | EP0571474A1 Orthomolecular method of treating sickle cell disease |
| 12/01/1993 | EP0544900A4 Transdermal nicotine absorption dosage unit and process |
| 12/01/1993 | EP0423289B1 Composition of beneficial agent and method for administering the same by controlled dissolution |
| 12/01/1993 | EP0267293B1 Pretreating agent for percutaneous administration |
| 12/01/1993 | EP0236476B1 Oxygenated perfluorinated perfusion of the ocular globe |
| 12/01/1993 | CN1078910A Biocompatible somatotropin solutions |
| 12/01/1993 | CN1078899A Specific plaster for spleen and stomach |
| 12/01/1993 | CN1078889A Improved pulsatile once-a-day-delivery systems for minocycline |
| 12/01/1993 | CN1078885A 磁药贴膏 Magnetic drug Plaster |
| 12/01/1993 | CN1078884A Stabilized solid pharmaceutical preparation and method of producing the same |
| 12/01/1993 | CN1078883A Dry and solid prickly-heat powder cake and its making method |
| 12/01/1993 | CN1022889C Process for "Touguxiang" pharmaceutical massage emulsion |
| 11/30/1993 | US5266723 Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids |
| 11/30/1993 | US5266683 Osteogenic proteins |
| 11/30/1993 | US5266581 Solid composition containing dihydropyridine, PVP and PVPP |
| 11/30/1993 | US5266571 Treatment of hemorrhoids with 5-HT2 antagonists |
| 11/30/1993 | US5266563 Hyakyribate-poly (ethylene oxide) mixtures |
| 11/30/1993 | US5266334 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 11/30/1993 | US5266333 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
| 11/30/1993 | US5266332 Method for administering anti-Parkinson drug |
| 11/30/1993 | US5266331 Controlled release oxycodone compositions |
| 11/30/1993 | US5266329 Controlled release fungicide or antibiotic such as clindamycin phosphate |
| 11/30/1993 | US5266325 Preparation of homogeneous hydrogel copolymers |
| 11/30/1993 | US5266205 Supercritical fluid reverse micelle separation |
| 11/30/1993 | CA2097164A1 Slow-release sodium valproate tablets |
| 11/30/1993 | CA2013755C Medicinal emulsions |
| 11/30/1993 | CA1324758C Transdermal antisecretory agents for gastrointestinal disease |
| 11/30/1993 | CA1324757C Transdermal administration using benzyl alcohol |
| 11/28/1993 | CA2096556A1 Fatty acid treatment |
| 11/27/1993 | CA2096902A1 Ophthalmic compositions containing vitamin e or ester thereof as an active ingredient |
| 11/25/1993 | WO1993023457A1 Conversion of powdered polymers |
| 11/25/1993 | WO1993023088A1 Biotherapeutic cell-coated microspheres |
| 11/25/1993 | WO1993023083A1 Anhydrous formulations for administering lipophilic agents |
| 11/25/1993 | WO1993023082A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/25/1993 | WO1993023079A1 Method for nonspecific cellular immune stimulation |
| 11/25/1993 | WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 11/25/1993 | WO1993023065A1 Pharmaceutical compositions containing il-6 |
| 11/25/1993 | WO1993023045A1 Use of cotinine to alleviate tobacco withdrawal syndrome |
| 11/25/1993 | WO1993023032A1 Remedy for cataract and production thereof |
| 11/25/1993 | WO1993023026A1 2-arylpropionic acid compositions and process for preparing the same |
| 11/25/1993 | WO1993023025A1 Transdermal administration of oxybutynin |
| 11/25/1993 | WO1993023022A1 Solid dispersion compositions of tebufelone |
| 11/25/1993 | WO1993023019A1 Transdermal drug delivery systems and related compositions and methods of use |
| 11/25/1993 | WO1993023018A1 Compositions in the form of films for the treatment of periodontolysis and fabrication process |
| 11/25/1993 | WO1993023017A1 Pharmaceutical and other dosage forms |
| 11/25/1993 | WO1993023016A1 Liposomal formulations containing rifamycins |
| 11/25/1993 | WO1993023015A1 Liposomal aminoglycoside compositions and process for their preparation |
| 11/25/1993 | WO1993023012A1 Liquid-containing drug delivery system |
| 11/25/1993 | WO1993023011A1 Transmucosal drug delivery device |
| 11/25/1993 | WO1993023010A1 Ophthalmic compositions containing a cyclosporin |
| 11/25/1993 | WO1993018764A3 Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration |
| 11/25/1993 | DE4315921A1 Pharmaceutical prepn. contg. cyclosporin(s) for intravenous use |
| 11/25/1993 | DE4216756A1 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung 2-arylpropionic acid preparations and methods for their preparation |
| 11/25/1993 | CA2136019A1 Use of cotinine to alleviate tobacco withdrawal syndrome |
| 11/25/1993 | CA2135784A1 Method for nonspecific cellular immune stimulation |
| 11/25/1993 | CA2135598A1 Anhydrous formulations for administering lipophilic agents |
| 11/25/1993 | CA2135302A1 Agent for treating cataract and method for its preparation |
| 11/25/1993 | CA2131101A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/24/1993 | EP0571338A1 Pharmaceutical oral controlled release composition comprising small pellets of bile acids |
| 11/24/1993 | EP0571264A1 Autoadhesive matrix system for the transdermal controlled release of piribedil |
| 11/24/1993 | EP0571217A2 Novel simethicone containing pharmaceutical compositions for treating gastrointestinal distress |
| 11/24/1993 | EP0571063A1 Pharmaceutical preparations |
| 11/24/1993 | EP0570829A1 Pharmaceutical composition for intravenous administration containing cyclosporin and method for its preparation |
| 11/24/1993 | EP0570714A2 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve |
| 11/24/1993 | EP0570606A1 Orally administrable solid medicine and process for preparing the same |
| 11/24/1993 | EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 11/24/1993 | EP0420862B1 Pharmaceutical composition containing deoxyribonucleosides for wound healing |